[Low bone mineral density in children with Crohn's disease]

O Bourges1, S Dorgeret, C Alberti

  • 1Service de gastroentérologie et de nutrition pédiatrique, hôpital Robert-Debré, AP-HP, 48, boulevard Serrurier, 75019 Paris, France.

Insights

Children with Crohn's disease frequently experience low bone mineral density, particularly during puberty. Daily corticosteroid use is a significant risk factor for osteoporosis in pediatric Crohn's disease patients.

Area of Science:

  • Pediatric Gastroenterology
  • Pediatric Endocrinology
  • Bone Metabolism

Context:

  • Crohn's disease (CD) is a chronic inflammatory condition affecting the gastrointestinal tract.
  • Low bone mineral density (BMD) is a recognized complication in adult CD patients.
  • Limited data exists on BMD in pediatric CD populations.

Purpose:

  • To determine the prevalence of low BMD in children with CD.
  • To identify risk factors associated with low BMD in this cohort.

Summary:

  • A retrospective study analyzed BMD in 29 children with CD using dual-energy X-ray absorptiometry.
  • Osteoporosis was diagnosed in 38% and osteopenia in 38% of participants.
  • Low BMD correlated with age, suggesting pubertal onset, and was significantly associated with daily corticosteroid exposure.

Impact:

  • This study highlights the high incidence of low BMD in pediatric CD, emphasizing the need for early screening and intervention.
  • Findings underscore the critical role of corticosteroid management in preventing bone loss.
  • Results suggest a need for revised treatment strategies to mitigate this common complication in pediatric CD.
Abstract

Related Concept Videos

Bone Disorders01:29

Bone Disorders

Aging and its effect on bone remodeling is the most common cause of bone disorders. In young and healthy people, bone deposition and resorption happen at an equal rate to maintain optimal bone health.
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Inflammatory Bowel Disease II: Crohn's Disease01:30

Inflammatory Bowel Disease II: Crohn's Disease

Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by transmural...
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the colonic...
Inflammatory Bowel Disease III: Crohn's Disease01:25

Inflammatory Bowel Disease III: Crohn's Disease

Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...